Healthcare [ 13/13 ] | Diagnostics & Research [ 77/164 ]
NASDAQ | Common Stock
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States.
It provides diagnostic blood cancer testing services.
The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
It offers biomarker testing and clinical project services to bio-pharma customers.
The company is based in New Haven, Connecticut.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 13, 24 | 0.65 Increased by +751.40% | - |
| Nov 13, 23 | -1.04 Decreased by -642.86% | -1.21 Increased by +14.05% |
| Aug 11, 23 | -0.09 Increased by 0.00% | -0.10 Increased by +10.00% |
| May 12, 23 | -0.13 Decreased by -85.71% | -0.13 |
| Mar 30, 23 | -0.10 Decreased by -11.11% | -0.14 Increased by +28.57% |
| Nov 10, 22 | -0.14 Decreased by -75.00% | -0.04 Decreased by -250.00% |
| Aug 11, 22 | -0.09 Increased by +35.71% | -0.08 Decreased by -12.50% |
| May 11, 22 | -0.07 Increased by +12.50% | -0.08 Increased by +12.50% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 4.33 M Increased by +81.05% | 925.00 K Increased by +140.08% | Increased by +21.37% Increased by +122.14% |
| Sep 30, 23 | 3.74 M Increased by +68.76% | -1.46 M Increased by +53.41% | Decreased by -38.92% Increased by +72.39% |
| Jun 30, 23 | 3.53 M Increased by +49.77% | -2.29 M Decreased by -24.01% | Decreased by -64.90% Increased by +17.20% |
| Mar 31, 23 | 2.82 M Increased by +15.12% | -3.04 M Increased by +30.40% | Decreased by -107.85% Increased by +39.54% |
| Dec 31, 22 | 2.39 M Decreased by -1.81% | -2.31 M Decreased by -4.67% | Decreased by -96.53% Decreased by -6.60% |
| Sep 30, 22 | 2.21 M Decreased by -1.38% | -3.12 M Decreased by -67.90% | Decreased by -140.99% Decreased by -70.25% |
| Jun 30, 22 | 2.36 M Increased by +0.64% | -1.85 M Increased by +38.63% | Decreased by -78.38% Increased by +39.02% |
| Mar 31, 22 | 2.45 M Increased by +34.16% | -4.37 M Decreased by -200.62% | Decreased by -178.38% Decreased by -124.08% |